Brain metastases are diagnosed in more than 50% of patients with advanced melanoma and are associated with a poor prognosis.
In this podcast, medical oncologist at Chris O’Brien Lifehouse Jenny Lee talks to Associate Professor Matteo Carlino, a consultant medical oncologist at Westmead and Blacktown about management of melanoma patients with symptomatic brain metastases and the data supporting treatment options beyond traditional radiotherapeutic approaches.
The views expressed in this podcast are the views of the presenters alone and are not necessarily reflective of the views of the sponsor. Please refer to the appropriate product information before prescribing any treatment mentioned in this podcast.
Associate Professor Matteo Carlino has served on advisory boards for Bristol-Myers Squibb, MSD, Amgen, Novartis, Pierre Fabre, Roche, Sanofi, Merck, Ideaya, Regeneron, Nektar, Eisai, Q biotics and honoraria from Bristol-Myers Squibb, MSD, Novartis
Jenny Lee has received honorarium (including travel support): BMS, AstraZeneca, Novartis, BioRad